Consultations

You are here

AVIS DE PROROGATION - CONSULTATION N°46-MED-2024 ERYTHROMYCINE COMP 500MG

by communication / 18 Apr, 2024

AVIS DE PROROGATION - CONSULTATION N°45-MED-2024 ERYTHROMYCINE SUSP ORALE 200MG-5ML

by communication / 18 Apr, 2024

AVIS DE CONSULTATION N°62-MED-2024 AMITRIPTYLINE COMP 50MG

by communication / 17 Apr, 2024

AVIS DE CONSULTATION N°61-MED-2024 - ACIDE VALPROIQUE COMP 500MG

by communication / 17 Apr, 2024

AVIS DE CONSULTATION N°60-MED-2024 ACIDE VALPROIQUE COMP 200MG

by communication / 17 Apr, 2024

AVIS DE CONSULTATION N°59-MED-2024 PHOSPHORE INJ SOUS FORME DE GLUCOSE 1 PHOSPHATE DISODIQUE 4 H2O

by communication / 16 Apr, 2024

AVIS DE CONSULTATION N°58-MED-2024 OLIGOÉLÉMENTS INJ

by communication / 16 Apr, 2024

AVIS DE CONSULTATION N°57-MED-2024 POLYVITAMINES (HYDROSOLUBLE ET LIPOSOLUBLE) INJ

by communication / 16 Apr, 2024

AVIS DE PROROGATION 2- CONSULTATION N°39-MED-2024 - CHARBON ACTIVE GRANULES POUR SUSPONSION BUVABLE 50G

by communication / 16 Apr, 2024

AVIS DE PROROGATION 2- CONSULTATION N°38-MED-2024 - CHARBON ACTIVÉ SUSPONSION BUVABLE 20G-100ML

by communication / 16 Apr, 2024

Pages

09789332719.png